Evaluation of a panel of in vitro methods for assessing thyroid receptor β and transthyretin transporter disrupting activities

Bérénice Collet; Eszter Simon; Sander van der Linden; Nadia el Abdellaoui; Matthijs Naderman; Hai yen Man; Irene Middelhof; Bart van der Burg; Harrie Besselink; Abraham Brouwer

doi:10.1016/j.reprotox.2019.05.011

Evaluation of a panel of in vitro methods for assessing thyroid receptor β and transthyretin transporter disrupting activities

Bérénice Collet^*
, Eszter Simon
, Sander van der Linden
, Nadia el Abdellaoui
, Matthijs Naderman
, Hai yen Man
, Irene Middelhof
, Bart van der Burg
, Harrie Besselink
, Abraham Brouwer

^*Corresponding author for this work

Research output: Contribution to Journal › Article › Academic › peer-review

223 Downloads (Pure)

Abstract

We developed a thyroid testing panel to assess endocrine disrupting chemicals (EDCs) capacities to bind either the thyroid receptor β (TRβ) or the thyroid hormones transporter transthyretin (TTR). We first stably transfected a human U2OS cell line with TRβ and a luciferase reporter construct to develop the TRβ CALUX® reporter gene assay to assess chemicals’ potential to interact with TRβ. Secondly, we combined a TTR-binding assay with the TRβ CALUX (TTR-TRβ CALUX) and optimized the system to evaluate the competitive properties of EDCs towards T4 for TTR binding. Both systems were evaluated with a range of known thyroid-disrupting compounds. The agonistic/antagonistic TRβ CALUX successfully predicted 9/9 and 9/12 test compounds, respectively. The TTR-TRβ CALUX predicted 9/9 compounds and demonstrated competitive activities when analyzing waste water samples. We concluded that the proposed test battery is a promising screening method able to efficiently generate data on thyroid hormone interferences by chemicals.

Original language	English
Pages (from-to)	432-444
Number of pages	13
Journal	Reproductive Toxicology
Volume	96
Early online date	8 May 2019
DOIs	https://doi.org/10.1016/j.reprotox.2019.05.011
Publication status	Published - Sept 2020

Funding

This project has received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No. 722634 . This project has received funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No. 722634.

Funders	Funder number
European Union's Horizon 2020 research and innovation program
European Union’s Horizon 2020 research and innovation program
Marie Sklodowska-Curie	722634

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 6 Clean Water and Sanitation

Keywords

Bioassay
CALUX
Endocrine disruption
Thyroid hormones
TTR binding potency
Water extract

Access to Document

10.1016/j.reprotox.2019.05.011

Evaluation of a panel of in vitro methods for assessing thyroid receptor β and transthyretin transporter disrupting activitiesFinal published version, 2.24 MBLicence: Article 25fa Dutch Copyright Act

Persistent URL (handle)

Persistent link

Cite this

Collet, B., Simon, E., van der Linden, S., el Abdellaoui, N., Naderman, M., Man, H. Y., Middelhof, I., van der Burg, B., Besselink, H., & Brouwer, A. (2020). Evaluation of a panel of in vitro methods for assessing thyroid receptor β and transthyretin transporter disrupting activities. Reproductive Toxicology, 96, 432-444. https://doi.org/10.1016/j.reprotox.2019.05.011

@article{07fd7e7e50d04af281f23a71d2176f4b,

title = "Evaluation of a panel of in vitro methods for assessing thyroid receptor β and transthyretin transporter disrupting activities",

abstract = "We developed a thyroid testing panel to assess endocrine disrupting chemicals (EDCs) capacities to bind either the thyroid receptor β (TRβ) or the thyroid hormones transporter transthyretin (TTR). We first stably transfected a human U2OS cell line with TRβ and a luciferase reporter construct to develop the TRβ CALUX{\textregistered} reporter gene assay to assess chemicals{\textquoteright} potential to interact with TRβ. Secondly, we combined a TTR-binding assay with the TRβ CALUX (TTR-TRβ CALUX) and optimized the system to evaluate the competitive properties of EDCs towards T4 for TTR binding. Both systems were evaluated with a range of known thyroid-disrupting compounds. The agonistic/antagonistic TRβ CALUX successfully predicted 9/9 and 9/12 test compounds, respectively. The TTR-TRβ CALUX predicted 9/9 compounds and demonstrated competitive activities when analyzing waste water samples. We concluded that the proposed test battery is a promising screening method able to efficiently generate data on thyroid hormone interferences by chemicals.",

keywords = "Bioassay, CALUX, Endocrine disruption, Thyroid hormones, TTR binding potency, Water extract",

author = "B{\'e}r{\'e}nice Collet and Eszter Simon and \{van der Linden\}, Sander and \{el Abdellaoui\}, Nadia and Matthijs Naderman and Man, \{Hai yen\} and Irene Middelhof and \{van der Burg\}, Bart and Harrie Besselink and Abraham Brouwer",

year = "2020",

month = sep,

doi = "10.1016/j.reprotox.2019.05.011",

language = "English",

volume = "96",

pages = "432--444",

journal = "Reproductive Toxicology",

issn = "0890-6238",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Evaluation of a panel of in vitro methods for assessing thyroid receptor β and transthyretin transporter disrupting activities

AU - Collet, Bérénice

AU - Simon, Eszter

AU - van der Linden, Sander

AU - el Abdellaoui, Nadia

AU - Naderman, Matthijs

AU - Man, Hai yen

AU - Middelhof, Irene

AU - van der Burg, Bart

AU - Besselink, Harrie

AU - Brouwer, Abraham

PY - 2020/9

Y1 - 2020/9

N2 - We developed a thyroid testing panel to assess endocrine disrupting chemicals (EDCs) capacities to bind either the thyroid receptor β (TRβ) or the thyroid hormones transporter transthyretin (TTR). We first stably transfected a human U2OS cell line with TRβ and a luciferase reporter construct to develop the TRβ CALUX® reporter gene assay to assess chemicals’ potential to interact with TRβ. Secondly, we combined a TTR-binding assay with the TRβ CALUX (TTR-TRβ CALUX) and optimized the system to evaluate the competitive properties of EDCs towards T4 for TTR binding. Both systems were evaluated with a range of known thyroid-disrupting compounds. The agonistic/antagonistic TRβ CALUX successfully predicted 9/9 and 9/12 test compounds, respectively. The TTR-TRβ CALUX predicted 9/9 compounds and demonstrated competitive activities when analyzing waste water samples. We concluded that the proposed test battery is a promising screening method able to efficiently generate data on thyroid hormone interferences by chemicals.

AB - We developed a thyroid testing panel to assess endocrine disrupting chemicals (EDCs) capacities to bind either the thyroid receptor β (TRβ) or the thyroid hormones transporter transthyretin (TTR). We first stably transfected a human U2OS cell line with TRβ and a luciferase reporter construct to develop the TRβ CALUX® reporter gene assay to assess chemicals’ potential to interact with TRβ. Secondly, we combined a TTR-binding assay with the TRβ CALUX (TTR-TRβ CALUX) and optimized the system to evaluate the competitive properties of EDCs towards T4 for TTR binding. Both systems were evaluated with a range of known thyroid-disrupting compounds. The agonistic/antagonistic TRβ CALUX successfully predicted 9/9 and 9/12 test compounds, respectively. The TTR-TRβ CALUX predicted 9/9 compounds and demonstrated competitive activities when analyzing waste water samples. We concluded that the proposed test battery is a promising screening method able to efficiently generate data on thyroid hormone interferences by chemicals.

KW - Bioassay

KW - CALUX

KW - Endocrine disruption

KW - Thyroid hormones

KW - TTR binding potency

KW - Water extract

UR - https://www.scopus.com/pages/publications/85065604031

UR - https://www.scopus.com/pages/publications/85065604031#tab=citedBy

U2 - 10.1016/j.reprotox.2019.05.011

DO - 10.1016/j.reprotox.2019.05.011

M3 - Article

C2 - 31077750

AN - SCOPUS:85065604031

SN - 0890-6238

VL - 96

SP - 432

EP - 444

JO - Reproductive Toxicology

JF - Reproductive Toxicology

ER -

Evaluation of a panel of in vitro methods for assessing thyroid receptor β and transthyretin transporter disrupting activities

Abstract

Funding

UN SDGs

Keywords

Access to Document

Persistent URL (handle)

Other files and links

Fingerprint

Cite this